Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

SNM1A Activators

The chemical class known as SNM1A activators encompasses a range of compounds that can activate the DNA repair protein SNM1A. These activators function primarily through their influence on various cellular pathways and DNA damage response processes. SNM1A, a protein involved in DNA crosslink repair and maintenance of genomic stability, plays a critical role in the cellular response to DNA damage. Activation of SNM1A is essential for efficient DNA repair, and chemicals that modulate the function of proteins and complexes within related pathways can indirectly enhance SNM1A activity.

Compounds that inhibit key proteins involved in the detection, signaling, and repair of DNA damage can shift the cellular reliance onto alternative pathways that engage SNM1A. By targeting proteins such as the MRE11-RAD50-NBS1 complex, ATR, and ATM kinases, which are primary responders to DNA strand breaks, these activators can alter the dynamics of the cellular repair processes. The necessity to maintain genomic integrity in the face of inhibited DNA damage response elements can lead to an increased activation of SNM1A. Likewise, inhibitors of PARP enzymes, which are pivotal in the repair of single-strand breaks, can result in an accumulation of DNA lesions that require homologous recombination, a process where SNM1A activity is crucial. The interplay between inhibited DNA repair pathways and the compensatory engagement of alternative mechanisms underlines the role of these chemicals as activators of SNM1A. These activators do not merely support the function of SNM1A in isolation but rather enhance its activity through a complex network of DNA repair and signaling pathways.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NU 7441

503468-95-9sc-208107
5 mg
$350.00
10
(2)

A DNA-PK inhibitor, NU7441 could possibly activate DCLRE1A by shifting the repair burden from the NHEJ pathway to the homologous recombination pathway.

ATM Kinase Inhibitor

587871-26-9sc-202963
2 mg
$108.00
28
(2)

An ATM kinase inhibitor. By inhibiting ATM, KU-55933 could possibly activate DCLRE1A as part of a compensatory increase in alternative DNA repair pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

A PARP inhibitor, Olaparib could possibly activate DCLRE1A by inducing a greater reliance on homologous recombination for the repair of DNA damage that accumulates when PARP is inhibited.

ATM/ATR Kinase Inhibitor Inhibitor

905973-89-9sc-202964
5 mg
$104.00
8
(1)

An inhibitor targeting both ATM and ATR kinases, CGK733 could possibly activate DCLRE1A by altering the DNA damage response and repair pathways.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
5 g
100 g
250 g
1 kg
5 kg
$32.00
$66.00
$95.00
$188.00
$760.00
13
(1)

Known to inhibit ATM and ATR kinases at high concentrations, caffeine could possibly activate DCLRE1A by modulating the DNA damage response.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

A broad-spectrum PI3K-related kinase inhibitor, Wortmannin could possibly activate DCLRE1A by affecting the equilibrium of DNA repair pathway choices.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A chemical inhibitor of PI3K and related kinases, LY294002 could possibly activate DCLRE1A by influencing the DNA repair mechanisms and cellular responses to DNA damage.